Offer - Urjas Oil for just ₹ 1 X
Glunil 5 Mg Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Diabetes Type 2. Secondary and off-label uses of Glunil 5 Mg Tablet have also been mentioned below.
The correct dosage of Glunil 5 Mg Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Glunil 5 Mg Tablet have been listed ahead. Usually, these side effects of Glunil 5 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Glunil 5 Mg Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Glunil 5 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Glunil 5 Mg Tablet related warnings section.
Individuals suffering from medical conditions like Liver Disease, Kidney Disease, Heart Disease must refrain from the use of Glunil 5 Mg Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Glunil 5 Mg Tablet contraindications section.
Drug interactions for Glunil 5 Mg Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Glunil 5 Mg Tablet, it is important to know that it is safe while driving, and is habit-forming.
Glunil 5 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glunil 5 Mg Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Glunil Tablet. If you are pregnant, do not take Glunil Tablet without a doctor's advice.
Is the use of Glunil 5 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Glunil Tablet. So it is adviced to consult the doctor before using it.
What is the effect of Glunil 5 Mg Tablet on the Kidneys?
Use of Glunil Tablet may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Glunil 5 Mg Tablet on the Liver?
Glunil Tablet can cause side effects that could harm the liver. So medical advice before taking it is necessary.
What is the effect of Glunil 5 Mg Tablet on the Heart?
Glunil Tablet has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Glunil 5 Mg Tablet unless your doctor advises you to do so -
Is this Glunil 5 Mg Tablet habit forming or addictive?
Forming a habit of Glunil 5 Mg Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Glunil 5 Mg Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Glunil 5 Mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Glunil 5 Mg Tablet is unable to treat or cure mental disorders.
Interaction between Food and Glunil 5 Mg Tablet
There isn't any research available on the side effects of taking Glunil 5 Mg Tablet with food.
Interaction between Alcohol and Glunil 5 Mg Tablet
Consuming Glunil 5 Mg Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272